首页> 美国卫生研究院文献>other >Review and Discussion of Tubular Biomarkers in the Diagnosis and Management of Diabetic Nephropathy
【2h】

Review and Discussion of Tubular Biomarkers in the Diagnosis and Management of Diabetic Nephropathy

机译:对糖尿病肾病诊断和管理中管状生物标志物的回顾与探讨

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prevalence of diabetic nephropathy has tremendously increased with the relentless rise in the incidence of diabetes over the last couple decades. Diabetic nephropathy is a leading cause of morbidity and mortality, and it invariably leads to an end stage renal disease (ERSD). In an effort to delay the onset of ESRD systematic screening and appropriate management are needed to evaluate the progression of renal damage in diabetic nephropathy. The reliability of current tests in predicting the onset, progression and response to various regimens for diabetic nephropathy is still under debate; and it has engendered a search for more sensitive and specific urinary biomarkers, especially those reflective of tubular dysfunctions. It is well known that there is a good correlation between the degree of damage to the tubulo-interstitial compartment and the deterioration of renal functions. In view of this, the utility of urinary biomarkers, reflective of tubular injury, reported in the literature is discussed in this brief review.
机译:在过去的几十年中,随着糖尿病发病率的不断提高,糖尿病肾病的患病率已大大增加。糖尿病肾病是发病率和死亡率的主要原因,并且总是导致终末期肾脏疾病(ERSD)。为了延缓ESRD的发作,需要系统的筛查和适当的管理以评估糖尿病性肾病中肾脏损害的进展。当前测试在预测糖尿病肾病的各种治疗方案的发作,进展和反应方面的可靠性仍存在争议。因此,人们开始寻找更敏感和更具体的尿液生物标志物,尤其是那些反映肾小管功能障碍的生物标志物。众所周知,肾小管间质细胞的损害程度与肾功能恶化之间存在良好的相关性。有鉴于此,在这篇简短的综述中讨论了文献中报道的反映尿管损伤的尿液生物标志物的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号